Related Experiment Video
Updated: Jun 26, 2025

05:17
Fast and Specific Assessment of the Halogenating Peroxidase Activity in Leukocyte-enriched Blood Samples
Published on: July 28, 2016
10.3K
Novel Myeloperoxidase Inhibitors for Treating Multiple Diseases
1Smith, Gambrell & Russell LLP, 1105 W. Peachtree Street NE, Suite 1000, Atlanta, Georgia 30309, United States.
ACS Medicinal Chemistry Letters
|May 15, 2024
Abstract:
Provided herein are novel myeloperoxidase inhibitors, pharmaceutical compositions, use of such compounds in treating inflammatory, cardiovascular, respiratory, renal, hepatic, and neurological diseases, cancer, and neutrophilic-driven diseases, and processes for preparing such compounds.

